General
Preferred name
MERICITABINE
Synonyms
R7128 ()
RG 7128 ()
R-7128 ()
PSI 6130 diisobutyrate ()
RG 7128, R-7128, PSI 6130 diisobutyrate ()
PSI 6130 DIISOBUTYRATE ()
RO5024048; R7128 ()
3',5'-DIISOBUTYRYL PSI 6130 ()
RO5024048 ()
R 7128 ()
RO-5024048 ()
P&D ID
PD012966
CAS
940908-79-2
Tags
prodrug
drug candidate
natural product
available
Drug indication
Hepatitis C virus infection
Drug Status
investigational
Max Phase
Phase 2
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
R-7128 is a selective nucleoside analog inhibitor of the hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase, with activity across all HCV genotypes. It is a nucleoside polymerase inhibitor (NPI) and is able to inhibit the RNA synthesis of HCV in vitro.
(BOC Sciences Bioactive Compounds)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
0
Organisms
1
Compound Sets
8
BOC Sciences Bioactive Compounds
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugMAP
MedChem Express Bioactive Compound Library
ReFrame library
Selleckchem Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
24
Molecular Weight
399.18
Hydrogen Bond Acceptors
9
Hydrogen Bond Donors
1
Rotatable Bonds
6
Ring Count
2
Aromatic Ring Count
1
cLogP
1.22
TPSA
122.74
Fraction CSP3
0.67
Chiral centers
4.0
Largest ring
6.0
QED
0.71
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
MOA
HCV inhibitor
Pathway
Anti-infection
Target
HCV
HCV Protease
Solubility
In vitro:<br/>10 mM in DMSO
Source data
